ALS United Connecticut Ends 2025 with Significant Research Investment
"Being part of this collaborative effort to uncover new treatments, cures, and the causes of ALS is truly inspiring," said
ALS United Connecticut expanded its research funding at a time when federal cuts threaten momentum in the field. By investing in high-impact scientific discovery, the organization continues to ensure progress does not stall for the ALS community.
Focused on maximizing impact through a centralized research program facilitated by the ALS Network, the partnership reduces infrastructure costs, eliminates duplication, and increases direct funding to fuel innovative, promising science. To learn more about ALS United Connecticut'sefforts visit ALSUnitedCT.org. To learn more about the ALS Network's leadership in facilitating collaborative research efforts visit alsnetwork.org/research.
About ALS United
ALS United is a collaborative network of independent nonprofit organizations across
About the ALS Network
The ALS Network partners with the ALS community to drive the discovery of prevention strategies, treatments, and cures for ALS; provide access to quality care and connection; and promote initiatives to improve health outcomes. The ALS Network, formerly ALS
Media Contact:
View original content to download multimedia:https://www.prnewswire.com/news-releases/als-united-connecticut-ends-2025-with-significant-research-investment-302650338.html
SOURCE ALS Network
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- PatientGain Eliminates Healthcare Website Headaches for Busy Practice Managers with VaultDocSites (TM)
- Endpoints News Announces the 2026 Winners of the Endpoints 11 Awards, showcasing biotech’s most exciting startups
- Bristol Myers Squibb Announces First Presentation of Results for ZENBEXUS™ (iberdomide) in Combination with Daratumumab from Phase 3 EXCALIBER-RRMM Trial in Relapsed or Refractory Multiple Myeloma
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share